Biostage (BSTG) Tops Q1 EPS by 9c

Biostage (NASDAQ: BSTG) reported Q1 EPS of ($0.14), $0.09 better than the analyst estimate of ($0.23).

The Company ended the quarter with approximately $6.6 million of cash.

For earnings history and earnings-related data on Biostage (BSTG) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown